Comparative Dissolution Testing
Comparative Dissolution Testing is a type of dissolution testing that evaluates and contrasts the release profiles of an active pharmaceutical ingredient from two or more formulations, typically to assess bioequivalence or the impact of formulation changes, under standardized experimental conditions.
242
Publications
8.7K
Citations
949
Authors
320
Institutions
Publications per year
2017–2026
46
Parents
Children
Batch-to-batch ComparisonComparative Release KineticsDissolution Method DiscriminationDissolution Profile VariabilityFormulation Effect ComparisonGeneric Product EquivalenceManufacturing Process Effects On DissolutionMultivariate Dissolution AnalysisPharmacopoeial Dissolution ComparisonQuality Control Dissolution Comparability
242
1–5 of 242
949
8
h-index
6
h-index
3
h-index
3
h-index
3
h-index
1–5 of 949
320
Goethe University Frankfurt
Frankfurt am Main, Germany
8 h-index
19 publications
1.1K citations
Boehringer Ingelheim (Germany)
Ingelheim, Germany
5 h-index
9 publications
388 citations
Center for Drug Evaluation and Research
Silver Spring, United States
4 h-index
8 publications
2.5K citations

University of Ibadan
Ibadan, Nigeria
4 h-index
9 publications
411 citations
Universidade de São Paulo
São Paulo, Brazil
4 h-index
11 publications
303 citations
Shenyang Pharmaceutical University
Shenyang, China
4 h-index
22 publications
589 citations
Heinrich Heine University Düsseldorf
Düsseldorf, Germany
4 h-index
11 publications
791 citations
University of Rhode Island
Kingston, United States
3 h-index
9 publications
549 citations
1–8 of 320
29 publications · 907 citations
19
h-index
26 publications · 594 citations
16
h-index
Repository · 10 publications · 251 citations
10
h-index
JPP · 9 publications · 575 citations
9
h-index
8 publications · 265 citations
8
h-index
1–5